Scientists from the Medical University of Gdańsk, Poltreg S.A. and Technische Universität Dresden published the description of new generation of medicinal product containing antigen-specific T regulatory cells. The work: „Antigen-reactive regulatory T cells can be expanded in vitro with monocytes and anti-CD28 and anti-CD154 antibodies” can be read in the Cytotherapy – official journal of the International Society of Cell and Gene Therapy. The product is intended for the treatment of autoimmune diseases. The paper summarizes the research and patent claimed under the same title last year.